Quad-Cities Investment Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-19,954
Closed -$297K 192
2025
Q1
$297K Buy
19,954
+4,743
+31% +$72.9K 0.15% 133
2024
Q4
$227K Buy
15,211
+4,146
+37% +$67.6K 0.11% 159
2024
Q3
$212K Buy
11,065
+72
+0.7% +$1.49K 0.11% 167
2024
Q2
$228K Buy
10,993
+67
+0.6% +$1.33K 0.13% 153
2024
Q1
$205K Buy
10,926
+76
+0.7% +$1.3K 0.12% 167
2023
Q4
$177K Buy
+10,850
New +$148K 0.11% 163

Other funds holding OGN

Quad-Cities Investment Group's OGN Position: Q2 2025 in Review

Quad-Cities Investment Group sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 19,954 shares — an estimated $297K sold.

Quad-Cities Investment Group first reported a position in OGN in Q4 2023 and held it in 6 quarters. The position peaked at $297K in Q1 2025. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Quad-Cities Investment Group reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Quad-Cities Investment Group sold 19,954 Organon & Co shares in Q2 2025, an estimated $297K.
  • Quad-Cities Investment Group first reported a position in Organon & Co in Q4 2023 and held it in 6 quarters.
  • Quad-Cities Investment Group's Organon & Co position peaked at $297K in Q1 2025.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Quad-Cities Investment Group's 13F filing for Q2 2025, filed 11 Jul 2025.